News | October 30, 2023
Dr Reddy's Q2 FY24 PAT jumps 33% to Rs 1,480 Cr
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Investment is additive to KKR’s existing health care growth strategy
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
New Board of Directors and management team at Suven Pharma also appointed
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Subscribe To Our Newsletter & Stay Updated
